These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7288429)

  • 21. Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by rat striatal neurons.
    Kerkerian L; Salin P; Nieoullon A
    Neuroscience; 1988 Sep; 26(3):809-17. PubMed ID: 3143926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo voltammetric study of dopamine release in the striatum following microinjection of apomorphine into the substantia nigra zona reticulata.
    Kamata K; Sugimoto A; Kameyama T
    Jpn J Pharmacol; 1986 Mar; 40(3):472-7. PubMed ID: 3712872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
    Fletcher GH; Starr MS
    Neuroscience; 1987 Dec; 23(3):1001-10. PubMed ID: 2963970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording.
    Grace AA; Bunney BS
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1092-100. PubMed ID: 3746660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low doses of apomorphine elicit two opposing influences on dopamine cell electrophysiology.
    Grace AA; Bunney BS
    Brain Res; 1985 May; 333(2):285-98. PubMed ID: 3995296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic treatment with haloperidol modifies the sensitivity of autoreceptors that modulate dopamine release in rat striatum.
    Yamada S; Yokoo H; Nishi S
    Eur J Pharmacol; 1993 Feb; 232(1):1-6. PubMed ID: 8458389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine D-2 auto- and postsynaptic receptors in the nigrostriatal system of the rat brain: localization by quantitative autoradiography with [3H]sulpiride.
    Filloux FM; Wamsley JK; Dawson TM
    Eur J Pharmacol; 1987 Jun; 138(1):61-8. PubMed ID: 3113982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition by apomorphine of the potassium-evoked release of [3H]-gamma-aminobutyric acid from the rat substantia nigra in vitro.
    Arbilla S; Kamal LA; Langer SZ
    Br J Pharmacol; 1981 Oct; 74(2):389-97. PubMed ID: 7317688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.
    Hu XT; Wachtel SR; Galloway MP; White FJ
    J Neurosci; 1990 Jul; 10(7):2318-29. PubMed ID: 1973947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
    Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
    Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasticity of [14C]2-deoxy-D-glucose incorporation into neostriatum and related structures in response to dopamine neuron damage and apomorphine replacement.
    Kozlowski MR; Marshall JF
    Brain Res; 1980 Sep; 197(1):167-83. PubMed ID: 7397550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of intrastriatal apomorphine on changes in switching behaviour induced by the glutamate agonist AMPA injected into the cat caudate nucleus.
    Jaspers RM; de Vries TJ; Cools AR
    Behav Brain Res; 1990 Mar; 37(3):247-54. PubMed ID: 2160249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons.
    Napier TC; Givens BS; Schulz DW; Bunney BS; Breese GR; Mailman RB
    J Pharmacol Exp Ther; 1986 Mar; 236(3):838-45. PubMed ID: 3512819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
    Bacopoulos NG; Roth RH
    Brain Res; 1981 Feb; 205(2):313-9. PubMed ID: 7470869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of dopamine agonists and antagonists on DOPA formation in the substantia nigra.
    Argiolas A; Melis MR; Fadda F; Serra G; Gessa GL
    J Neurochem; 1982 Jan; 38(1):75-9. PubMed ID: 6809898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Voltammetry in unanesthetized rat: increases of striatal dopamine turnover after unilateral haloperidol injection into the substantia nigra.
    Kato T; Ishii K; Ikeda M
    Neurosci Lett; 1984 Sep; 50(1-3):263-7. PubMed ID: 6493630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decrease of behavioral and biochemical denervation supersensitivity of rat striatum by nigral transplants.
    Rioux L; Gaudin DP; Gagnon C; Di Paolo T; Bédard PJ
    Neuroscience; 1991; 44(1):75-83. PubMed ID: 1770999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apomorphine increases the activity of rat globus pallidus neurons.
    Bergstrom DA; Bromley SD; Walters JR
    Brain Res; 1982 Apr; 238(1):266-71. PubMed ID: 7083021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
    Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation by haloperidol of the catalepsy produced by lesions in the parafascicular nucleus of the rat.
    Ahlenius S
    Brain Res; 1978 Jul; 150(3):648-52. PubMed ID: 567086
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.